Cabot (NYSE:CBT) Given a $82.00 Price Target at UBS Group

Key Points

• UBS Group has raised Cabot's price target from $81.00 to $82.00, indicating a potential upside of 11.13% based on the company's previous close, while maintaining a "neutral" rating.
• Separately, Wall Street Zen downgraded Cabot from a "buy" to a "hold" rating, reflecting differing sentiment among analysts.
• Cabot's latest quarterly earnings report revealed an EPS of $1.90, surpassing estimates, but revenue fell short at $923 million against analyst expectations of $957 million.

UBS Group set a $82.00 price target on Cabot (NYSE:CBT - Free Report) in a research report report published on Tuesday, MarketBeat reports. The firm currently has a neutral rating on the specialty chemicals company's stock.

Separately, Wall Street Zen lowered shares of Cabot from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th.

Cabot Price Performance

CBT stock opened at $77.52 on Tuesday. The firm's fifty day moving average is $75.86 and its 200 day moving average is $79.72. Cabot has a 52 week low of $70.40 and a 52 week high of $117.46. The firm has a market cap of $4.16 billion, a P/E ratio of 10.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.30 and a current ratio of 2.13.

Cabot (NYSE:CBT - Get Free Report) last issued its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.10. The firm had revenue of $923.00 million for the quarter, compared to analysts' expectations of $957.29 million. Cabot had a net margin of 11.14% and a return on equity of 25.68%. Research analysts predict that Cabot will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 11th. Stockholders of record on Friday, August 29th will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.3%. Cabot's dividend payout ratio is currently 23.29%.

Hedge Funds Weigh In On Cabot

Large investors have recently modified their holdings of the stock. Geneos Wealth Management Inc. lifted its stake in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock valued at $38,000 after acquiring an additional 364 shares during the period. Banque Cantonale Vaudoise purchased a new stake in shares of Cabot during the 1st quarter valued at about $43,000. CWM LLC grew its position in Cabot by 55.0% during the first quarter. CWM LLC now owns 600 shares of the specialty chemicals company's stock valued at $50,000 after buying an additional 213 shares during the period. UMB Bank n.a. grew its position in shares of Cabot by 52.4% during the 2nd quarter. UMB Bank n.a. now owns 730 shares of the specialty chemicals company's stock valued at $55,000 after acquiring an additional 251 shares during the period. Finally, Brooklyn Investment Group grew its holdings in Cabot by 1,553.7% during the first quarter. Brooklyn Investment Group now owns 678 shares of the specialty chemicals company's stock valued at $56,000 after purchasing an additional 637 shares during the period. Hedge funds and other institutional investors own 93.18% of the company's stock.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.